Aspire Biopharma Holdings Inc
NASDAQ:ASBP
Aspire Biopharma Holdings Inc
NASDAQ:ASBP
Price:
1.02
USD
0.99%
Market Cap:
$5.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Aspire Biopharma Holdings Inc
NASDAQ:ASBP
|
PR |
|
Onconetix Inc
NASDAQ:ONCO
|
US |
|
Wisdom Education International Holdings Company Ltd
HKEX:6068
|
CN |
|
N
|
Navan Inc
NASDAQ:NAVN
|
US |
|
International Endeavors Corp
OTC:IDVV
|
US |
|
S
|
Sable Exploration and Mining Ltd
JSE:SXM
|
ZA |
|
AllDigital Holdings Inc
OTC:ADGL
|
US |
|
Freewon China Co Ltd
SSE:688678
|
CN |
|
G
|
Guangzhou Rural Commercial Bank Co Ltd
HKEX:1551
|
CN |
|
C
|
Chu Kong Petroleum and Natural Gas Steel Pipe Holdings Ltd
HKEX:1938
|
CN |
|
M
|
Medcamp SA
WSE:MDP
|
PL |
|
G
|
Goto Ltd
TASE:GOTO
|
IL |
|
I
|
Infant Bacterial Therapeutics AB
STO:IBT B
|
SE |
|
Mizrahi Tefahot Bank Ltd
OTC:MZTFF
|
IL |
|
P
|
Profound Medical Corp
NASDAQ:PROF
|
CA |
|
P
|
Paliburg Holdings Ltd
HKEX:617
|
HK |
|
iEntertainment Network Inc
OTC:IENT
|
US |
Multiples-Based Value
The Multiples-Based Value of one
ASBP
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 1.02 USD,
Aspire Biopharma Holdings Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ASBP Multiples-Based Value
LOCKED
Multiples Across Competitors
ASBP Competitors Multiples
Aspire Biopharma Holdings Inc Competitors
Aspire Biopharma Holdings Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| PR |
|
Aspire Biopharma Holdings Inc
NASDAQ:ASBP
|
5.1m USD | 1 858.1 | -0.1 | -0.7 | -0.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD | 13.5 | 42.7 | 28.8 | 30.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD | 6.2 | 21.9 | 15.2 | 18.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP | 5.4 | 31.2 | 17.2 | 24.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD | 4.6 | 16.4 | 10.1 | 12.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF | 5.4 | 21.8 | 13.5 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD | 2.6 | 20.6 | 7.9 | 10.5 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
